The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’-Reference-Cited by-同舟云学术

The unique presentation of SARS-CoV-2 Infection in patients with B-cell depletion: definition of ‘persistent inflammatory sero-negative COVID’

Published:2023-01 Issue:1 Volume:29 Page:1-3
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Belkin Ana,Leibowitz Avshalom,Shargian Liat,Yahav Dafna

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Prolonged viral positivity induced recurrent coronavirus disease 2019 (COVID-19) pneumonia in patients receiving anti-CD20 monoclonal antibody treatment: case reports;Deveci;Case Rep Med (Baltimore),2021

2. Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies;Lee;Cancer Discov,2022

3. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?;Gousseff;J Infect,2020

4. Vaccination for SARS-CoV-2 in hematological patients;Riccardi;Acta Haematol,2022

5. Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection in patients treated with anti-CD20 monoclonal antibodies;Calderón-Parra;Clin Infect Dis,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab;Virology Journal;2023-12-15

2. Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID‐19: A prospective cohort study;Journal of Medical Virology;2023-11

3. Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients;Upsala Journal of Medical Sciences;2023-10-11

4. Early combination with remdesivir, nirmatrelvir/ritonavir and sotrovimab for the treatment of COVID-19 in immunocompromised hosts;2023-10-09

5. Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series;Antibiotics;2023-09-19